TerminatedNot Applicable

Clinical and Urgent Colonoscopy Outcomes Using the Pure-Vu® Cleansing System

Stopped: Difficulty recruiting

United States6 participantsStarted 2021-03-03

Plain-language summary

The Pure-Vu® System can be effectively used as a cleansing device in patients admitted with acute LGIB to the intensive care unit and the regular nurse floor (RNF) bypassing the need to administer an oral bowel preparation for adequate visualization and hence decreasing time to colonoscopy and improving diagnostic and therapeutic yield.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hospitalized patients in the ICU or the RNF with acute LGIB (defined as maroon-colored stool or bright red blood per rectum with suspicion of acute blood loss anemia, and hemodynamically stable and/or stabilized at the time of procedure . Hospitalized patients include: * Patients who develop LGIB while admitted for different reasons * Patients transferred from an outside hospital for further management of acute LGIB * Patients admitted through the emergency room for management of acute LGIB * At least 22 years old * Undergoing urgent colonoscopy under monitored anesthesia care or conscious sedation Exclusion Criteria: * Suspicion for bowel obstruction/ stricture * Toxic megacolon or severe colitis (determined by degree of colitis on imaging and clinical condition including pain, fevers, abdominal exam, elevated inflammatory markers) * Active Diverticulitis

What they're measuring

Adequate Bowel Preparation

Timeframe: During the colonoscopy procedure, typically less than 1 hour

Trial details

NCT IDNCT04729946

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-06

View on ClinicalTrials.gov More Lower Gastrointestinal Bleeding trials